Stock 8095 ASTENA HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Astena Holdings Co., Ltd.

Equities

8095

JP3150000002

Pharmaceuticals

Delayed Japan Exchange
Other stock markets
 07:00:00 02/05/2024 BST 		5-day change 1st Jan Change
492 JPY +0.20% Intraday chart for Astena Holdings Co., Ltd. +0.82% +3.36%
2022 Tranche Update on Astena Holdings Co., Ltd.'s Equity Buyback Plan announced on July 13, 2022. CI
2022 Astena Holdings Co., Ltd.'s Equity Buyback announced on July 13, 2022 has closed with 676,400 shares, representing 1.69% for ¥299.97 million. CI

Valuation

Fiscal Period: November 2018 2019 2020 2021 2022 2023
Capitalization 1 17,115 15,473 17,339 19,375 16,124 19,633
Enterprise Value (EV) 1 16,500 15,686 21,963 23,603 24,216 29,674
P/E ratio 12.1 x 10.1 x 8.72 x 10.4 x 28.7 x 16.9 x
Yield 1.99% 2.75% 3.04% 3.7% 4.32% 3.62%
Capitalization / Revenue 0.28 x 0.25 x 0.27 x 0.27 x 0.32 x 0.38 x
EV / Revenue 0.27 x 0.25 x 0.34 x 0.33 x 0.49 x 0.57 x
EV / EBITDA 6.33 x 5.33 x 6.45 x 5.81 x 8.24 x 8.87 x
EV / FCF 27.9 x -57.6 x 10.1 x -9.26 x -8.29 x -12.1 x
FCF Yield 3.59% -1.74% 9.94% -10.8% -12.1% -8.29%
Price to Book 0.89 x 0.76 x 0.8 x 0.72 x 0.61 x 0.69 x
Nbr of stocks (in thousands) 32,416 32,712 32,964 39,866 38,666 39,503
Reference price 2 528.0 473.0 526.0 486.0 417.0 497.0
Announcement Date 22/02/19 26/02/20 24/02/21 25/02/22 22/02/23 28/02/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: November 2018 2019 2020 2021 2022 2023
Net sales 1 60,083 61,647 65,341 72,322 49,636 51,984
EBITDA 1 2,607 2,943 3,404 4,064 2,937 3,344
EBIT 1 1,852 2,125 2,035 2,234 820 1,128
Operating Margin 3.08% 3.45% 3.11% 3.09% 1.65% 2.17%
Earnings before Tax (EBT) 1 1,978 2,304 2,588 3,078 1,418 1,559
Net income 1 1,414 1,533 1,983 1,736 579 1,162
Net margin 2.35% 2.49% 3.03% 2.4% 1.17% 2.24%
EPS 2 43.73 47.00 60.31 46.63 14.54 29.45
Free Cash Flow 1 592.1 -272.2 2,184 -2,548 -2,922 -2,460
FCF margin 0.99% -0.44% 3.34% -3.52% -5.89% -4.73%
FCF Conversion (EBITDA) 22.71% - 64.15% - - -
FCF Conversion (Net income) 41.88% - 110.11% - - -
Dividend per Share 2 10.50 13.00 16.00 18.00 18.00 18.00
Announcement Date 22/02/19 26/02/20 24/02/21 25/02/22 22/02/23 28/02/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: November 2020 S1 2021 S1 2022 Q1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1
Net sales 1 30,832 36,249 12,285 24,934 11,994 12,785 26,857 13,817 13,426
EBITDA - - - - - - - - -
EBIT 1 878 1,495 630 720 -294 -92 208 477 454
Operating Margin 2.85% 4.12% 5.13% 2.89% -2.45% -0.72% 0.77% 3.45% 3.38%
Earnings before Tax (EBT) 1 912 1,552 658 1,463 -339 -84 68 560 393
Net income 1 592 975 449 932 -326 -206 -227 436 249
Net margin 1.92% 2.69% 3.65% 3.74% -2.72% -1.61% -0.85% 3.16% 1.85%
EPS 2 18.05 28.06 11.26 23.33 -8.160 -5.240 -5.780 11.10 6.320
Dividend per Share 7.000 9.000 - 9.000 - - 9.000 - -
Announcement Date 10/07/20 09/07/21 13/04/22 13/07/22 12/10/22 13/04/23 13/07/23 13/10/23 12/04/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: November 2018 2019 2020 2021 2022 2023
Net Debt 1 - 213 4,624 4,228 8,092 10,041
Net Cash position 1 615 - - - - -
Leverage (Debt/EBITDA) - 0.0724 x 1.358 x 1.04 x 2.755 x 3.003 x
Free Cash Flow 1 592 -272 2,184 -2,548 -2,922 -2,460
ROE (net income / shareholders' equity) 7.68% 7.79% 9.43% 7.13% 2.12% 4.14%
ROA (Net income/ Total Assets) 2.89% 3.08% 2.57% 2.37% 0.81% 1.08%
Assets 1 48,872 49,745 77,205 73,280 71,801 107,802
Book Value Per Share 2 592.0 624.0 656.0 677.0 685.0 719.0
Cash Flow per Share 2 146.0 150.0 229.0 274.0 176.0 174.0
Capex 1 681 1,093 1,308 2,935 2,770 3,820
Capex / Sales 1.13% 1.77% 2% 4.06% 5.58% 7.35%
Announcement Date 22/02/19 26/02/20 24/02/21 25/02/22 22/02/23 28/02/24
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ASTENA HOLDINGS CO., LTD. Stock Astena Holdings Co., Ltd.
+3.36% 123M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.68% 699B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.07% 571B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.35% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.65% 326B
ABBVIE INC. Stock AbbVie Inc.
+3.77% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.68% 236B
NOVARTIS AG Stock Novartis AG
+4.71% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-12.43% 194B
PFIZER, INC. Stock Pfizer, Inc.
-3.79% 154B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 8095 Stock
  4. Financials Astena Holdings Co., Ltd.